Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.48
0.130.80%
Last update: Jan 16, 2:24 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MoonLake (MLTX) stock?
You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.
Who are MoonLake (MLTX) competitors?
Other companies in MoonLake’s space includes: ARS Pharmaceuticals Inc (NASDAQ:SPRY), Immatics NV (NASDAQ:IMTX), CareDx Inc (NASDAQ:CDNA), Day One Biopharmaceuticals Inc (NASDAQ:DAWN) and NuCana PLC (NASDAQ:NCNA).
What is the forecast, or price target, for MoonLake (MLTX) stock?
MoonLake has a consensus price target of $43.29.
What is the current price for MoonLake (MLTX)?
The stock price for MoonLake (NASDAQ: MLTX) is $16.48 last updated January 16, 2026 at 2:24 PM EST.
Does MoonLake (MLTX) pay a dividend?
There are no upcoming dividends for MoonLake.
When is MoonLake (NASDAQ:MLTX) reporting earnings?
MoonLake does not have any upcoming earnings scheduled.
Is MoonLake (MLTX) going to split?
There is no upcoming split for MoonLake.
What sector and industry does MoonLake (MLTX) operate in?
MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
